- Journalist, writer and broadcaster Carl Anka blogs honestly about his fears and concerns around donating and how he overcame them to do an 'amazing' and 'selfless' act. My…
- This is Martin. After his stem cell transplant in 2014, he decided he wanted to volunteer for Anthony Nolan in not just one role, but several. We think he’s fantastic. Here,…
- Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem…
- Daniel Gibson, Head of Innovation and Commercialisation talks about the advancements in cellular therapy research, and how we are overcoming critical issues in the supply of…
- When Doug found out about the need to diversify the stem cell register, he immediately signed up. This Black History Month, he wants to spread the word about the difference…
- Jonathan in our patient services team discusses emerging treatments for cancer, using cell therapy and new ‘super cells’. When developing a new cancer treatment, one of the most…
- After new findings from Anthony Nolan’s Patient/Donor project have been published, Jonathan from our Patient Services team looks at how new technology is helping us understand…
- After the news that the Scottish Medicine Consortium has recommended letermovir (Prevymis) for routine use on the NHS in Scotland, Bradley from our Policy and Public Affairs team…
- Young people have a very mixed understanding of what stem cell donation involves. In this blog, Anthony Nolan’s Chief Executive Henny Braund explains how new guidelines from the…
- After being diagnosed with essential thrombocythemia (ET), Colin’s blood disorder developed into myelofibrosis, a rare type of bone cancer. Here, he talks about his two stem cell…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.